
Latest news, updates, and announcements from Peptris.

Bengaluru-based Peptris has secured $7.7M in Series A funding to scale its AI-powered drug discovery platform, pepAI, which can reduce preclinical development from 5 years to 1.5 years and cut costs f...

Bengaluru-based Peptris raised Rs 70 crore (USD 7.7M) Series A to advance AI-generated drugs to clinical stage within 24 months, targeting oncology, rare diseases, and women's health. This signals Ind...